SEC Filings for Anika Therapeutics Inc. (ANIK)

$ 42.75   0.75 (+1.79%) Volume: 374.94k 4:00 PM EST 21-Feb-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals411/20/2018
4Statement of changes in beneficial ownership of securities110/30/2018
10-QGeneral form for quarterly reports under Section 13 or 15(d)2810/26/2018
3Initial statement of beneficial ownership of securities210/25/2018
4Statement of changes in beneficial ownership of securities110/25/2018
8-KCurrent report pursuant to Section 13 or 15(d)310/24/2018
8-KCurrent report pursuant to Section 13 or 15(d)910/24/2018
8-KCurrent report pursuant to Section 13 or 15(d)309/05/2018
3Initial statement of beneficial ownership of securities109/05/2018
4Statement of changes in beneficial ownership of securities109/05/2018
10-QGeneral form for quarterly reports under Section 13 or 15(d)5107/31/2018
8-KCurrent report pursuant to Section 13 or 15(d)907/25/2018
8-KCurrent report pursuant to Section 13 or 15(d)506/19/2018
8-KCurrent report pursuant to Section 13 or 15(d)3006/06/2018
8-KCurrent report pursuant to Section 13 or 15(d)305/29/2018
123456789101112131415